AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aquestive Therapeutics, Inc. Director's Dealing 2018

Jul 25, 2018

32552_dirs_2018-07-24_e7cd89f1-1869-42d2-bd74-0081f5f9da74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-07-24

Reporting Person: BROWN GREGORY B (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75085	Direct

Footnotes

F1: Represents shares of the Issuer's non-voting common stock. The non-voting shares will become regular voting common stock upon the consummation of the Issuer's initial public offering.